Skip to main navigation Skip to search Skip to main content

Treatment with zoledronic acid in hormone-refractory prostate cancer patients with bone metastases: The risk of renal impairment

  • Mari Nakabayashi
  • , William K. Oh

Research output: Contribution to journal › Review article › peer-review

Original languageEnglish
Pages (from-to)566-568
Number of pages3
JournalAmerican Journal of Hematology/ Oncology
Volume6
Issue number10
StatePublished - Oct 2007
Externally publishedYes

Cite this